Celgene (CELG) PT Lifted at Nomura Post Q1

Go back to Celgene (CELG) PT Lifted at Nomura Post Q1

UPDATE: Piper Jaffray Upgrades Celgene (CELG) to Overweight

April 25, 2014 6:47 AM EDT

(Updated - April 25, 2014 7:28 AM EDT)

Piper Jaffray upgraded Celgene (NASDAQ: CELG) from Neutral to Overweight.

Analyst Joshua E. Schimmer said, "CELG shares have lagged over the past few months, lately as part of a sluggish biotech... More